Thanks for your interest in our recent webinar in partnership with Select Science. Watch as Dr. Milena Milutinovic from Quanterix and Dr. Nicholas Ashton from the University of Gothenburg highlight the role of Simoa® technology in the identification and validation of novel biomarkers. Learn about the potential of this technology to transform the drug approval process and patient management. Dr. Ashton also reviewed the gaps in blood biomarker research and shared how his work is addressing this need. The discussion demonstrated how Simoa® technology is advancing neurological research and the clinical utility of blood-based biomarkers.